Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study

Detalles Bibliográficos
Autores principales: Nam, Chang Hyun, Byun, Ja Min, Shin, Dong-Yeop, Hong, Junshik, Kim, Inho, Yoon, Sung-Soo, Koh, Youngil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2021
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478612/
https://www.ncbi.nlm.nih.gov/pubmed/34462405
http://dx.doi.org/10.5045/br.2021.2021067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478612/
https://www.ncbi.nlm.nih.gov/pubmed/34462405
http://dx.doi.org/10.5045/br.2021.2021067

Ejemplares similares